key: cord-0928751-bxpjxwsz
authors: Speranskaya, AS; Kaptelova, VV; Valdokhina, AV; Bulanenko, VP; Samoilov, AE; Korneenko, EV; Shipulina, OY; Akimkin, VG
title: SCV-2000bp: a primer panel for SARS-CoV-2 full-genome sequencing
date: 2020-08-04
journal: bioRxiv
DOI: 10.1101/2020.08.04.234880
sha: c96888ff0a900a5849e4582c6467e7db650a1cdb
doc_id: 928751
cord_uid: bxpjxwsz

Here we provide technical data for amplifying the complete genome of SARS-CoV-2 from clinical samples using only seventeen pairs of primers. We demonstrate that the СV2000bp primer panel successfully produces genomes when used with the residual total RNA extracts from positive clinical samples following diagnostic RT-PCRs (with Ct in the range from 13 to 20). The library preparation method reported here includes genome amplification of ~1750-2000 bp fragments followed by ultrasonic fragmentation combined with the introduction of Illumina compatible adapters. Using the SCV2000bp panel, 25 complete SARS-CoV-2 virus genome sequences were sequenced from clinical samples of COVID-19 patients from Moscow obtained in late March - early April.

Presently, the SARS-CoV-2 pandemic has been raging in every country in the world, since it started in China in late 2019. The primary objective of epidemiological surveillance during the pandemic is to track its geographical spread, and this activity should continue throughout the pandemic. Analyzing the genome of SARS-CoV-2 from clinical samples is crucial for the understanding of viral spread and evolution as well as for timely developing epidemiology response strategies. Achieving these goals locally and nationally requires genome sequencing methods development.

NGS is the current mainstream method for SARS-CoV-2 genome sequencing. One of the most widely used approaches is the ARTIC protocol which includes 98 pairs of primers divided into two multiplex PCR reactions and covers almost the whole region of SARS-CoV-2 genome [1, 2] . ARTIC protocol is popular, and its existing modifications improve the coverage of sequencing regions [3] . Nevertheless, it has some irreparable drawbacks, for example, a lot of short amplification fragments; as a result, it has a reduced ability to amplify the degenerative variants of virus genomes. [4] . Another drawback is a large number of oligonucleotides (totally 196 primers), so the total price for their synthesis could significantly limit the capabilities of small local laboratories for the production of genomic data due to the high input cost of experiments. There is a need for a decrease of the cost of library preparation for high-throughput sequencing.

Here we present a new primer panel which allows amplifying the complete genome of SARS-CoV-2 (the causative virus of COVID-19) using 17 primer pairs (in four pools). Our results demonstrate that our method allows producing full genomes when we use RNA extract 

The swab samples from patients with symptoms of acute respiratory infections or suspected for SARS-CoV-2 were processed at the Molecular diagnostic laboratory of Federal Budget where the presence of SARS-CoV-2 was determined with a cycle threshold (Ct) <= 20. Before the work started, these RNA samples had been stored carelessly in the clinical lab under nonspecialized conditions for 2-3 months.

The primer scheme for amplifying the whole genome of SARS-CoV-2 was initially designed using a web-based primer design tool -Primal Scheme [5, 6] . As a result, 17 primer pairs were designed. Thirty most variable SARS-CoV-2 full genome sequences available at the GenBank as of 30.03.2000 were used as reference genomes. The parameter of amplicon lengths of 2000 nts with a 100-nt overlap was used for the scheme generation. Then the designed primers were manually corrected and combined in pools. Subsequently, the primer combinations were optimized using iterative sequencing of some randomly selected samples on Illumina MiSeq. Finally, the designed primers were mixed equally into four pools, each containing from 2 to 6 primer pairs (see Table 1 ). 

Reverse transcription reaction was performed using 10 μL of the RNA samples, random hexanucleotide primers and Reverta-L kit (AmpliSens, Russia) according to the manufacturer's instructions. The cDNA was immediately used as a template for the amplification of genome fragments.

The ~2000 bp SARS-CoV-2 genome fragments were amplified using the designed primers. The multiplex PCR amplification reaction was performed in the volume of 25-μL, containing 5-8 μL of the template cDNA (see Table 2 .), 2 μL of the pooled primers (for the concentration see Table 2 .), 0,5 μL of dNTPs (10 mM, Thermo Fisher Scientific, USA), Q5

High-Fidelity DNA Polymerase and polymerase buffer according to the manufacturer's instructions (New England BioLabs, NEB). The PCR amplifications were performed using 96 well plates and Veriti™ 96-Well Thermal Cycler (Thermo Fisher Scientific). 

The premixed and purified PCR products (of 17-300 ng per sample) were sheared in 

To process raw reads of multiple samples, we have utilized a pipeline consisting of mainstream bioinformatics tools. In short, reads were trimmed by quality with Trimmomatic [7] . PCR primers were removed using Cutadapt [8] . Resulting reads were mapped to reference genome MT121215.1 using bowtie2 [9] . Reads with low mapping quality were filtered out using SAMtools [10] . Basecalling was performed with GATK [11] . Gvcf files were filtered with BCFtools [12] , and the consensus sequence was obtained with BEDTools [13] . Finally, the validity of the obtained sequence was verified manually by mapping reads to the consensus sequence followed by visual inspection. Areas with read coverage lower than 5 were masked with NNN.

We have developed a multiplex system to amplify the long nucleic acid fragments of The synthesizing of cDNA from input RNA using random primers followed by the polymerase chain reaction with specific primers is the most common method for amplifying RNA viruses to obtain sufficient coverage and depth of the whole viral genome. For NGS library preparation, we used the same RNA samples which were the remains of clinical diagnostic (i.e. without repeating the stage of RNA extraction). All the analyzed samples showed the Ct value in the range of 13 to 20 (i.e. a high virus load). Under the conditions described in Materials and Methods, multiplex PCR successfully produced fragments of the expected length. The amplification was generally less effective for pool 1 and pool 2 primers (most likely due to the presence of unspecific products) (See Figure 3) . lanes (250bp, 500bp, 750bp, 2x1000bp, 1500 bp,   2000bp, 2500bp, 2x3000bp, 4000bp, 5000bp, 6000bp, 8000bp, 10000bp) .

The primer panel was tested with many different RNA samples, namely, we tested 233 samples with Ct from 13 to 26. Some samples failed in amplification with pool1, pool 2, and even with all four primer pools. Since our goal was to develop a method for sequencing viral genomes using the RNA samples remaining after diagnostic in the clinical labs, we tried to find a method for preliminary selection of promising samples directly from a great number of samples. Some authors claim that "poor quality consensus genomes were generally associated with a lower SARS-CoV-2 viral load in the clinical samples i.e. higher RT-qPCR Ct values" [14] . Therefore, we check the impact of Ct values differences on the successful genome amplification. We amplified only the second pool because it worked worst of all and checked the results of amplification using gel electrophoresis. We found that the number of successful amplifications is strongly related to the collection date and storage conditions of samples, but not to Ct value (See Table 2 ). Another reasonable explanation of the poor results of amplification was the degradation of the extracted RNA. So, we measured total RNA integrity number (RIN) using Agilent

Bioanalyzer 2100 for a set of samples and found that successful amplification, sequencing and assembling could be achieved even for samples containing fully degraded RNA, see Table 3 .

The samples which are marked bold in Table 3 , namely A1063, A1134, A1102, A1106 and A1076 were successfully amplified, sequenced and assembled, although their quality was extremely bad. And vice versa, even if RNA had RIN >5 (i.e. good enough quality), this did not guarantee the success of amplification. For example, see sample A1135, Table 3 . 

We developed a primer set for a relatively inexpensive generation of genomic data for SARS-CoV-2. Previously, a multiplexed PCR primer set for whole genome analysis of SARS-CoV-2 (ARTIC Network) was proposed by [1, 2, 3] . Currently, this is the most widely used approach. The cost of oligonucleotides synthesis for the ARTIC primer set is about 11980$ (if 5o.e. for each primer synthesized). So, the input price of experiments is high and could be a hindrance for researchers in small local labs with limited financial capabilities. Therefore, it is advisable to have a battery of methods for complete SARS-CoV-2 genome amplification. The cost of СV2000bp primer panel oligonucleotide synthesis is only 2300$. We demonstrate that this primer panel can be successfully used for sequencing and assembling of SARS-CoV-2 genomes both by ligation adapters approach and by tagmentation-based library construction if total RNA extracts from positive samples with Ct in the range from 13 to 20. Moreover, many research laboratories are not licensed to work with samples containing live SARS-CoV-2 viruses, so they have to deal with the remains of the RNAs extracted from oropharyngeal swabs in diagnostic labs. The library preparation methods described in this manuscript could be used for the complete genome sequencing of SARS-CoV-2 even from the samples which are remains of diagnostic tests in clinical labs.

SARS-CoV-2 Updates

A Proposal of an alternative primer fortheARTIC Network's multiplex PCR to improve coverage of SARS-CoV-2 genome sequencing

2020 Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

Trimmomatic: a flexible trimmer for Illumina sequence data

Cutadapt removes adapter sequences from high-throughput sequencing reads

Fast gapped-read alignment with Bowtie 2

The sequence alignment/map format and SAMtools

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data

BCFtools/csq: haplotype-aware variant consequences

BEDTools: a flexible suite of utilities for comparing genomic features

CoronaHiT: large scale multiplexing of SARS-CoV-2 genomes using Nanopore sequencing